APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 13 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,511,675 | -75.5% | 1,195,000 | -53.7% | 0.00% | -100.0% |
| Q2 2023 | $6,164,667 | +3145138.3% | 2,581,000 | +1885.4% | 0.00% | – |
| Q4 2022 | $196 | -100.0% | 130,000 | -87.3% | 0.00% | – |
| Q3 2022 | $1,937,000 | +1293.5% | 1,025,000 | +1002.2% | 0.00% | – |
| Q2 2022 | $139,000 | -96.8% | 93,000 | -96.8% | 0.00% | -100.0% |
| Q4 2021 | $4,366,000 | +36.1% | 2,884,000 | +9.7% | 0.00% | – |
| Q3 2021 | $3,207,000 | -76.9% | 2,629,000 | -73.6% | 0.00% | -100.0% |
| Q1 2021 | $13,902,000 | +2.4% | 9,944,000 | +21.1% | 0.00% | 0.0% |
| Q4 2020 | $13,576,000 | +826.7% | 8,214,000 | +494.4% | 0.00% | – |
| Q3 2020 | $1,465,000 | – | 1,382,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 15,000,000 | $35,954,355 | 1.42% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $28,207,024 | 0.34% |
| LINDEN ADVISORS LP | 10,000,000 | $23,952,985 | 0.25% |
| Verition Fund Management LLC | 4,796 | $11,487,633 | 0.15% |
| LORD, ABBETT & CO. LLC | 11,712,000 | $28,044 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,267,000 | $3,044,070 | 0.08% |
| LAZARD ASSET MANAGEMENT LLC | 14,242,000 | $34,113 | 0.04% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $717,076 | 0.01% |
| D. E. Shaw & Co., Inc. | 5,000,000 | $11,995,383 | 0.01% |
| Citadel Advisors | 11,500,000 | $27,556,934 | 0.01% |